Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes.


Journal

United European gastroenterology journal
ISSN: 2050-6414
Titre abrégé: United European Gastroenterol J
Pays: England
ID NLM: 101606807

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 15 9 2020
medline: 13 7 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

Extra-intestinal manifestations (EIMs) of inflammatory bowel disease (IBD) occur frequently and contribute to morbidity and reduced quality of life. The musculoskeletal, ocular and cutaneous organ systems are frequently involved in IBD-related EIMs. By focusing on manifestations involving the joints, skin and eyes, this review will discuss the most common clinically relevant and burdensome EIMs that affect IBD patients, and strives for early recognition, adequate treatment and timely referral. For this purpose, we aimed to create a comprehensive overview on this topic, with the main focus on the treatment of reactive and associated EIMs, including spondyloarthropathies, pyoderma gangrenosum, erythema nodosum, psoriasis and anterior uveitis. The recently developed biologicals enable simultaneous treatment of inflammatory disorders. This review can be used as a helpful guide in daily clinical practice for physicians who are involved in the treatment of IBD patients.

Identifiants

pubmed: 32921269
doi: 10.1177/2050640620958902
pmc: PMC7724540
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Mesalamine 4Q81I59GXC
Prednisolone 9PHQ9Y1OLM

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1031-1044

Références

Lancet. 2018 Jul 14;392(10142):134-144
pubmed: 29961640
J Crohns Colitis. 2020 Jan 1;14(1):33-45
pubmed: 31219157
JAMA. 2017 Nov 28;318(20):2019-2032
pubmed: 29183082
Ann Rheum Dis. 2011 Jan;70(1):25-31
pubmed: 21109520
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528
pubmed: 11087881
Clin Gastroenterol Hepatol. 2006 Feb;4(2):203-11
pubmed: 16469681
Br J Ophthalmol. 1976 Mar;60(3):163-91
pubmed: 1268179
JAMA Dermatol. 2018 Apr 1;154(4):409-413
pubmed: 29450453
Clin Gastroenterol Hepatol. 2016 Jan;14(1):65-70
pubmed: 25952308
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Ann Rheum Dis. 2009 Jun;68(6):784-8
pubmed: 19147614
Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1502-1506
pubmed: 30148806
J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94
pubmed: 26481193
Dig Liver Dis. 2013 Mar;45(3):195-9
pubmed: 23200464
World J Gastroenterol. 2017 Aug 28;23(32):5836-5848
pubmed: 28932076
Medicine (Baltimore). 1976 Sep;55(5):401-12
pubmed: 957999
Autoimmun Rev. 2014 Aug;13(8):822-30
pubmed: 24726868
J Crohns Colitis. 2016 Apr;10(4):455-61
pubmed: 26721937
J Am Acad Dermatol. 2019 Apr;80(4):1073-1113
pubmed: 30772097
Aliment Pharmacol Ther. 2013 Sep;38(6):563-72
pubmed: 23914999
N Engl J Med. 2002 Oct 31;347(18):1412-8
pubmed: 12409543
Clin Gastroenterol Hepatol. 2017 Jan;15(1):25-36.e27
pubmed: 27392760
Inflamm Bowel Dis. 2015 Aug;21(8):1982-92
pubmed: 26154136
J Crohns Colitis. 2019 Jan 1;13(1):50-57
pubmed: 30203005
Clin Pharmacol Ther. 2020 May;107(5):1189-1199
pubmed: 31677154
World J Gastroenterol. 2017 Dec 14;23(46):8182-8192
pubmed: 29290654
J Am Acad Dermatol. 2017 Jan;76(1):49-53
pubmed: 27793450
Expert Opin Biol Ther. 2020 Jun;20(6):621-633
pubmed: 32077334
PLoS One. 2019 Jan 25;14(1):e0210436
pubmed: 30682031
Lancet. 2015 Sep 5;386(9997):983-94
pubmed: 26025581
Inflamm Bowel Dis. 2020 Jan 1;26(1):114-124
pubmed: 31127829
Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):307-317
pubmed: 30791773
Ann Rheum Dis. 2018 Dec;77(12):1730-1735
pubmed: 30076154
World J Gastroenterol. 2019 May 14;25(18):2162-2176
pubmed: 31143068
Int J Colorectal Dis. 2007 Sep;22(9):1027-30
pubmed: 17262200
Gut. 1998 Mar;42(3):387-91
pubmed: 9577346
Ann Rheum Dis. 2015 Aug;74(8):1483-7
pubmed: 25990288
Aliment Pharmacol Ther. 2019 Dec;50(11-12):1204-1213
pubmed: 31650573
Ann Rheum Dis. 2006 Sep;65(9):1147-53
pubmed: 16606646
Inflamm Bowel Dis. 2016 Jan;22(1):106-13
pubmed: 26422515
J Gastroenterol Hepatol. 2014 Feb;29(2):291-5
pubmed: 23927379
J Crohns Colitis. 2017 May 1;11(5):631-642
pubmed: 28453761
Inflamm Bowel Dis. 2015 Aug;21(8):1794-800
pubmed: 26020601
JAMA Dermatol. 2018 Apr 1;154(4):461-466
pubmed: 29450466
Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1250-1256
pubmed: 30353756
J Am Acad Dermatol. 2019 Jan;80(1):60-69.e2
pubmed: 29860040
Ann Rheum Dis. 2017 Mar;76(3):491-496
pubmed: 27991858
Front Immunol. 2018 Nov 28;9:2746
pubmed: 30555460
Aliment Pharmacol Ther. 2018 Feb;47(4):485-493
pubmed: 29250803
Gut. 2006 Mar;55 Suppl 1:i36-58
pubmed: 16481630
Inflamm Bowel Dis. 2017 Jul;23(7):1174-1181
pubmed: 28452862
Clin J Gastroenterol. 2019 Dec;12(6):501-510
pubmed: 30838512
Clin Rev Allergy Immunol. 2017 Dec;53(3):413-427
pubmed: 28643285
Gut. 2011 Oct;60(10):1426-35
pubmed: 21551189
J Crohns Colitis. 2020 Aug 1;14(Supplement_2):S761-S766
pubmed: 31922534
Clin Gastroenterol Hepatol. 2006 Feb;4(2):196-202
pubmed: 16469680
Gut. 2006 Apr;55(4):505-9
pubmed: 16188920
J Crohns Colitis. 2016 Jan;10(1):43-9
pubmed: 26449790
Am J Gastroenterol. 2001 Apr;96(4):1116-22
pubmed: 11316157
Therap Adv Gastroenterol. 2019 Aug 13;12:1756284819865142
pubmed: 31447932
J Crohns Colitis. 2019 Apr 26;13(5):541-554
pubmed: 30445584
Clin Exp Immunol. 2019 Apr;196(1):123-138
pubmed: 30554407
J Crohns Colitis. 2016 Feb;10(2):166-75
pubmed: 26512134
Digestion. 2014;90(2):122-9
pubmed: 25277851
Expert Opin Investig Drugs. 2019 May;28(5):473-479
pubmed: 30884245
J Crohns Colitis. 2016 Apr;10(4):429-36
pubmed: 26721936
J Crohns Colitis. 2016 Mar;10(3):239-54
pubmed: 26614685
Aliment Pharmacol Ther. 2018 Jun;47(11):1428-1439
pubmed: 29620794

Auteurs

Fenna M Jansen (FM)

Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Stephan R Vavricka (SR)

Department of Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Alfons A den Broeder (AA)

³Department of Medicine, Division of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.

Elke Mgj de Jong (EM)

Department of Medicine, Division of Dermatology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Frank Hoentjen (F)

Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Willemijn A van Dop (WA)

Department of Medicine, Division of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH